Dignity Health Integrates Asthma and COPD Data, Sees 54% Drop in ER Visits

Digital therapeutics, remote patient monitoring and SMART FHIR add up to boost outcomes and reduce costs.

CommonSpirit is developing the digital capabilities and clinical and administrative processes to provide these services, which will enable patients to have greater control over their care, empower education, increase engagement, target improved clinical outcomes and further support population health management. "Propeller Health's FDA-cleared platform is one of the digital therapeutics services that is offered to help our patients and their clinicians in the disease management of chronic asthma and COPD and to help improve clinical quality outcomes and reduce costs of care," said Dr. Francisco Rhein, vice president of innovation and digital care transformation at CommonSpirit Health.